Demographics |
5 |
Least influential |
4 |
Less influential |
— |
Not ranked |
Age, % |
|
0 |
|
1 |
|
|
Sex, % |
|
0 |
|
1 |
|
|
Race, % |
|
0 |
|
1 |
|
|
Disease factors |
4 |
Less influential |
1 |
Most influential |
— |
Not ranked |
Systemic sclerosis subtype, % |
|
3 |
|
7 |
|
|
Disease duration, % |
|
2 |
|
31 |
|
|
ANA status, % |
|
0 |
|
1 |
|
|
Systemic sclerosis autoantibody status, % |
|
2 |
|
11 |
|
|
Modified Rodnan Skin Score, % |
|
0 |
|
1 |
|
|
Patient reported outcome measures |
3 |
Influential |
5 |
Least influential |
3 |
Least influential |
Baseline Dyspnoea Index/Transition Index, % |
|
19 |
|
1 |
|
6 |
Leicester Cough Questionnaire, % |
|
1 |
|
0 |
|
0 |
Patient global assessment, % |
|
1 |
|
0 |
|
1 |
St George’s Respiratory Questionnaire, % |
|
3 |
|
1 |
|
2 |
Spirometry and gas exchange |
1 |
Most influential |
2 |
Very influential |
1 |
Most influential |
Forced vital capacity, % |
|
29 |
|
17 |
|
48 |
Diffusion capacity of carbon monoxide, % |
|
11 |
|
5 |
|
6 |
Quantitative high resolution chest CT |
2 |
Very influential |
3 |
Influential |
2 |
Influential |
Total lung involvement, % |
|
25 |
|
15 |
|
29 |
Total lung fibrosis, % |
|
5 |
|
6 |
|
8 |